Loading...
Header Logo
Keywords
Last Name
Institution

ABHIJIT MAZUMDAR

TitleAssistant Professor
InstitutionMD Anderson
DepartmentClinical Cancer Prevention
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tan X, Banerjee P, Pham EA, Rutaganira FUN, Basu K, Bota-Rabassedas N, Guo HF, Grzeskowiak CL, Liu X, Yu J, Shi L, Peng DH, Rodriguez BL, Zhang J, Zheng V, Duose DY, Solis LM, Mino B, Raso MG, Behrens C, Wistuba II, Scott KL, Smith M, Nguyen K, Lam G, Choong I, Mazumdar A, Hill JL, Gibbons DL, Brown PH, Russell WK, Shokat K, Creighton CJ, Glenn JS, Kurie JM. PI4KIIIß is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma. Sci Transl Med. 2020 01 22; 12(527). PMID: 31969487.
      View in: PubMed
    2. Bollu LR, Shepherd J, Zhao D, Ma Y, Tahaney W, Speers C, Mazumdar A, Mills GB, Brown PH. Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1. NPJ Breast Cancer. 2020; 6:2. PMID: 31909186.
      View in: PubMed
    3. Mandi M, Khatun S, Rajak P, Mazumdar A, Roy S. Potential risk of organophosphate exposure in male reproductive system of a non-target insect model Drosophila melanogaster. Environ Toxicol Pharmacol. 2020 Feb; 74:103308. PMID: 31816565.
      View in: PubMed
    4. Mazumdar A, Tahaney WM, Reddy Bollu L, Poage G, Hill J, Zhang Y, Mills GB, Brown PH. The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression. NPJ Breast Cancer. 2019; 5:22. PMID: 31372497.
      View in: PubMed
    5. Zhao D, Tahaney WM, Mazumdar A, Savage MI, Brown PH. Molecularly targeted therapies for p53-mutant cancers. Cell Mol Life Sci. 2017 11; 74(22):4171-4187. PMID: 28643165.
      View in: PubMed
    6. Bollu LR, Mazumdar A, Savage MI, Brown PH. Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer. Clin Cancer Res. 2017 May 01; 23(9):2136-2142. PMID: 28087641.
      View in: PubMed
    7. Ghosh TS, Chatterjee S, Azmi SA, Mazumdar A, Dangar TK. Virulence assay and role of Bacillus thuringiensis TS110 as biocontrol agent against the larval stages of rice leaffolder Cnaphalocrocis medinalis. J Parasit Dis. 2017 Jun; 41(2):491-495. PMID: 28615866.
      View in: PubMed
    8. Mazumdar A, Poage GM, Shepherd J, Tsimelzon A, Hartman ZC, Den Hollander P, Hill J, Zhang Y, Chang J, Hilsenbeck SG, Fuqua S, Kent Osborne C, Mills GB, Brown PH. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Breast Cancer Res Treat. 2016 08; 158(3):441-54. PMID: 27393618.
      View in: PubMed
    9. Shepherd JH, Uray IP, Mazumdar A, Tsimelzon A, Savage M, Hilsenbeck SG, Brown PH. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression. Oncotarget. 2016 Mar 15; 7(11):13106-21. PMID: 26894864.
      View in: PubMed
    10. Malorni L, Giuliano M, Migliaccio I, Wang T, Creighton CJ, Lupien M, Fu X, Hilsenbeck SG, Healy N, De Angelis C, Mazumdar A, Trivedi MV, Massarweh S, Gutierrez C, De Placido S, Jeselsohn R, Brown M, Brown PH, Osborne CK, Schiff R. Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance. Mol Cancer Res. 2016 05; 14(5):470-81. PMID: 26965145.
      View in: PubMed
    11. den Hollander P, Rawls K, Tsimelzon A, Shepherd J, Mazumdar A, Hill J, Fuqua SA, Chang JC, Osborne CK, Hilsenbeck SG, Mills GB, Brown PH. Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival. Cancer Res. 2016 04 01; 76(7):1942-53. PMID: 26921331.
      View in: PubMed
    12. Rajput S, Puvvada N, Kumar BN, Sarkar S, Konar S, Bharti R, Dey G, Mazumdar A, Pathak A, Fisher PB, Mandal M. Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes. Mol Pharm. 2015 Dec 07; 12(12):4214-25. PMID: 26505213.
      View in: PubMed
    13. Puvvada N, Rajput S, Kumar BNP, Sarkar S, Konar S, Brunt KR, Rao RR, Mazumdar A, Das SK, Basu R, Fisher PB, Mandal M, Pathak A. Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression. Sci Rep. 2015 Jul 06; 5:11760. PMID: 26145450.
      View in: PubMed
    14. Zhao J, Zhao D, Poage GM, Mazumdar A, Zhang Y, Hill JL, Hartman ZC, Savage MI, Mills GB, Brown PH. Death-associated protein kinase 1 promotes growth of p53-mutant cancers. J Clin Invest. 2015 Jul 01; 125(7):2707-20. PMID: 26075823.
      View in: PubMed
    15. Paul N, Mazumdar A. Chaudhuriomyia, a new tanypod genus of Macropelopiini (Diptera: Chironomidae: Tanypodinae) from the Eastern Himalaya. Zootaxa. 2015 May 06; 3955(4):537-48. PMID: 25947870.
      View in: PubMed
    16. Paul N, Harsha R, Mazumdar A. A new species of Forcipomyia Meigen (Diptera: Ceratopogonidae) described with immature stages from India. Zootaxa. 2014 Nov 04; 3881(2):165-74. PMID: 25543627.
      View in: PubMed
    17. Kumar BNP, Puvvada N, Rajput S, Sarkar S, Das SK, Emdad L, Sarkar D, Venkatesan P, Pal I, Dey G, Konar S, Brunt KR, Rao RR, Mazumdar A, Kundu SC, Pathak A, Fisher PB, Mandal M. Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy. J Mater Chem B. 2015 Jan 07; 3(1):90-101. PMID: 32261929.
      View in: PubMed
    18. Paul N, Hazra N, Mazumdar A. Monopelopia mongpuense sp. n., a phytotelmata midge from sub-Himalayan region of India (Diptera: Chironomidae: Tanypodinae). Zootaxa. 2014 May 23; (3802):122-30. PMID: 24870997.
      View in: PubMed
    19. Paul N, Mazumdar A. A new species of Palpomyia Meigen (Diptera: Ceratopogonidae) described in all life stages from Shillong plateau, India . Zootaxa. 2014 Jan 23; 3755:368-78. PMID: 24869826.
      View in: PubMed
    20. Kumar BN, Rajput S, Dey KK, Parekh A, Das S, Mazumdar A, Mandal M. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer. 2013 Jun 03; 13:273. PMID: 23731702.
      View in: PubMed
    21. Hartman ZC, Poage GM, den Hollander P, Tsimelzon A, Hill J, Panupinthu N, Zhang Y, Mazumdar A, Hilsenbeck SG, Mills GB, Brown PH. Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 2013 Jun 01; 73(11):3470-80. PMID: 23633491.
      View in: PubMed
    22. Mazumdar A, Medina D, Kittrell FS, Zhang Y, Hill JL, Edwards DE, Bissonnette RP, Brown PH. The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice. Cancer Prev Res (Phila). 2012 Oct; 5(10):1195-202. PMID: 22926341.
      View in: PubMed
    23. Wang C, Uray IP, Mazumdar A, Mayer JA, Brown PH. SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE). Breast Cancer Res Treat. 2012 Jul; 134(1):101-15. PMID: 22212555.
      View in: PubMed
    24. Wang C, Mayer JA, Mazumdar A, Brown PH. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells. Breast Cancer Res Treat. 2012 Jun; 133(2):487-500. PMID: 21947652.
      View in: PubMed
    25. Wang C, Mayer JA, Mazumdar A, Fertuck K, Kim H, Brown M, Brown PH. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Mol Endocrinol. 2011 Sep; 25(9):1527-38. PMID: 21835891.
      View in: PubMed
    26. Jaganathan SK, Mazumdar A, Mondhe D, Mandal M. Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int. 2011 Jun; 35(6):607-15. PMID: 21044050.
      View in: PubMed
    27. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M. ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells. J Cell Physiol. 2011 Feb; 226(2):375-84. PMID: 20665703.
      View in: PubMed
    28. Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, Mandal M. ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells. Cancer Biol Ther. 2010 Apr 15; 9(8):592-603. PMID: 20139705.
      View in: PubMed
    29. Mazumdar A, Henderson YC, El-Naggar AK, Sen S, Clayman GL. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck. 2009 May; 31(5):625-34. PMID: 19107951.
      View in: PubMed
    30. Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. J Exp Ther Oncol. 2008; 7(4):299-312. PMID: 19227010.
      View in: PubMed
    31. Bagheri-Yarmand R, Mazumdar A, Sahin AA, Kumar R. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int J Cancer. 2006 Jun 01; 118(11):2703-10. PMID: 16381000.
      View in: PubMed
    32. Shellenberger TD, Mazumdar A, Henderson Y, Briggs K, Wang M, Chattopadhyay C, Jayakumar A, Frederick M, Clayman GL. Headpin: a serpin with endogenous and exogenous suppression of angiogenesis. Cancer Res. 2005 Dec 15; 65(24):11501-9. PMID: 16357159.
      View in: PubMed
    33. Mishra SK, Yang Z, Mazumdar A, Talukder AH, Larose L, Kumar R. Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-gamma2, an estrogen-responsive kinase. Oncogene. 2004 May 27; 23(25):4422-9. PMID: 15077195.
      View in: PubMed
    34. Pai VR, Mazumdar AT, Deshmukh CD, Bakshi AV, Parikh DM, Parikh PM, Mistry RC, Pathak KA, D'Cruz AK. Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patients. Med Oncol. 2004; 21(4):305-8. PMID: 15579913.
      View in: PubMed
    35. Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, Yu W, Jordan VC, Santen RJ, Kumar R. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J Biol Chem. 2003 May 23; 278(21):19209-19. PMID: 12639951.
      View in: PubMed
    36. Mazumdar A, Kumar R. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Lett. 2003 Jan 30; 535(1-3):6-10. PMID: 12560069.
      View in: PubMed
    37. Pai VR, Mazumdar AT, Deshmukh CD, Bakshi AV, Parikh DM, Parikh PM, Mistry RC, Pathak KA. Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: a retrospective analysis of 519 patients: a single institution experience. Med Oncol. 2003; 20(1):1-5. PMID: 12665677.
      View in: PubMed
    38. Wang RA, Mazumdar A, Vadlamudi RK, Kumar R. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J. 2002 Oct 15; 21(20):5437-47. PMID: 12374744.
      View in: PubMed
    39. Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature. 2002 Aug 08; 418(6898):654-7. PMID: 12167865.
      View in: PubMed
    40. Mishra SK, Mandal M, Mazumdar A, Kumar R. Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells. FEBS Lett. 2001 Oct 19; 507(1):88-94. PMID: 11682064.
      View in: PubMed
    41. Vadlamudi RK, Wang RA, Mazumdar A, Kim Y, Shin J, Sahin A, Kumar R. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J Biol Chem. 2001 Oct 12; 276(41):38272-9. PMID: 11481323.
      View in: PubMed
    42. Bilanges B, Varrault A, Mazumdar A, Pantaloni C, Hoffmann A, Bockaert J, Spengler D, Journot L. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities. Oncogene. 2001 Mar 08; 20(10):1246-53. PMID: 11313869.
      View in: PubMed
    43. Mazumdar A, Adam L, Boyd D, Kumar R. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Cancer Res. 2001 Jan 01; 61(1):400-5. PMID: 11196194.
      View in: PubMed
    44. Mazumdar A, Wang RA, Mishra SK, Adam L, Bagheri-Yarmand R, Mandal M, Vadlamudi RK, Kumar R. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol. 2001 Jan; 3(1):30-7. PMID: 11146623.
      View in: PubMed
    45. Adam L, Mazumdar A, Sharma T, Jones TR, Kumar R. A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2. Cancer Res. 2001 Jan 01; 61(1):81-7. PMID: 11196203.
      View in: PubMed
    46. Bilanges B, Varrault A, Basyuk E, Rodriguez C, Mazumdar A, Pantaloni C, Bockaert J, Theillet C, Spengler D, Journot L. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene. 1999 Jul 08; 18(27):3979-88. PMID: 10435621.
      View in: PubMed
    47. Pai VR, Parikh DM, Mazumdar AT, Rao RS. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck. Oncology. 1993 Mar-Apr; 50(2):86-91. PMID: 8451041.
      View in: PubMed
    48. Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy. Journal of Materials Chemistry B. 3:90-101.
    49. Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression. Scientific Reports. 5.
    50. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression. Oncotarget. 7:13106-13121.
    51. Phosphatase PTP4A3 promotes triple-negative breast cancer growth and predicts poor patient survival. Cancer Research. 76:1942-1953.
    52. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion. Breast Cancer Research and Treatment. 1-14.
    53. Blockade of AP-1 potentiates endocrine therapy and overcomes resistance. Molecular Cancer Research. 14:470-481.
    MAZUMDAR's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description